PHARMACOKINETICS AND RECTAL BIOAVAILABILITY OF HYDROCORTISONE ACETATE

被引:14
|
作者
MOLLMANN, H
BARTH, J
MOLLMANN, C
TUNN, S
KRIEG, M
DERENDORF, H
机构
[1] UNIV FLORIDA,COLL PHARM,DEPT PHARMACEUT,BOX J-494,GAINESVILLE,FL 32610
[2] RUHR UNIV BOCHUM,MED CLIN,W-4630 BOCHUM,GERMANY
关键词
D O I
10.1002/jps.2600800906
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The pharmacokinetics and bioavailability of hydrocortisone after rectal administration of a hydrocortisone acetate foam was determined. Endogenous hydrocortisone was suppressed by dexamethasone administration. Plasma levels were compared with those observed after iv and oral administration. Only a very small part of the rectal dose (100 mg) was absorbed; the mean absolute bioavailability was 2%. There was substantial intersubject variability. Maximum hydrocortisone levels were reached after 2 h and averaged 35 ng/mL. These levels were 10-fold lower than those obtained after oral administration of a fivefold lower dose (20 mg) of hydrocortisone in the same subjects.
引用
收藏
页码:835 / 836
页数:2
相关论文
共 50 条
  • [21] RECTAL MOTILITY AND BIOAVAILABILITY
    TUKKER, JJ
    DEBLAEY, CJ
    CHARBON, GA
    PHARMACEUTICAL RESEARCH, 1984, (04) : 173 - 178
  • [22] FORMULATION, BIOAVAILABILITY AND PHARMACOKINETICS OF RECTAL ADMINISTRATION OF LORAZEPAM SUPPOSITORIES AND COMPARISON WITH ORAL SOLUTION IN MONGREL DOG
    SINGH, J
    JAYASWAL, SB
    PHARMAZEUTISCHE INDUSTRIE, 1985, 47 (06): : 664 - 668
  • [23] BIOAVAILABILITY AND PHARMACOKINETICS OF CIMETIDINE
    GRAHNEN, A
    BAHR, CV
    LINDSTROM, B
    ROSEN, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (05) : 335 - 340
  • [24] PHENYTOIN - PHARMACOKINETICS AND BIOAVAILABILITY
    GUGLER, R
    MANION, CV
    AZARNOFF, DL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1976, 19 (02) : 135 - 142
  • [25] BIOAVAILABILITY AND PHARMACOKINETICS OF FEMOXETINE
    MENGEL, H
    LUND, J
    LANGE, J
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1983, 33-1 (03): : 462 - 466
  • [26] METHOTREXATE - BIOAVAILABILITY AND PHARMACOKINETICS
    CAMPBELL, MA
    PERRIER, DG
    DORR, RT
    ALBERTS, DS
    FINLEY, PR
    CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 833 - 838
  • [27] CHLORPROPAMIDE BIOAVAILABILITY AND PHARMACOKINETICS
    HUUPPONEN, R
    LAMMINTAUSTA, R
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1981, 19 (07) : 331 - 333
  • [28] BIOAVAILABILITY AND PHARMACOKINETICS OF OXAZEPAM
    SONNE, J
    LOFT, S
    DOSSING, M
    VOLLMERLARSEN, A
    OLESEN, KL
    VICTOR, M
    ANDREASEN, F
    ANDREASEN, PB
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (04) : 385 - 389
  • [29] DISOPYRAMIDE PHARMACOKINETICS AND BIOAVAILABILITY
    DUBETZ, DK
    BROWN, NN
    HOOPER, WD
    EADIE, MJ
    TYRER, JH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (03) : 279 - 281
  • [30] DISPOSITION OF INTRA-ARTICULARLY INJECTED HYDROCORTISONE ACETATE, HYDROCORTISONE FREE ALCOHOL AND CORTISONE ACETATE IN ARTHRITIS
    ZACCO, M
    RICHARDSON, EM
    CRITTENDEN, JO
    DOHAN, FC
    HOLLANDER, JL
    EXPERIENTIA, 1955, 11 (07): : 279 - 280